LSIPMS

LSIPMS Life Sciences Industrial Pharmaceutical Manufacturing Symposium is a health care alliance focused on public health emergencies and in restructuring the pharmaceutical manufacturing supply chain disruption in the United States and abroad.  

LSIPMS serves as a liaison for local, state and federal agencies as well as for the health care industry and academia, combining regulatory compliance, life sciences, policy making, research and development while building valuable bridges and finding solutions towards the future of the restructuring of the health care system.  

Our goal is to be able to contribute and build a resilient and sustainable domestic pharmaceutical manufacturing supply chain, and to bring and help develop new innovative products, manufacturing and strategies to help reduce the cost of pharmaceutical drugs and medical products while making them more accesible to the general public and to patients in need.   

Our well specialized FDA regulatory affairs team is capable to design anything from clinical trials Phase 1-2-3, product development and all the way until product approval and commercialization. This includes product development, biologics and vaccines, immunotherapy treatments, medical devices, drug development and more. 

During FITCE 2023 we were honored to present the special theme: Life Science, Innovation and Technology under LSIPMS Life Sciences Industrial Pharmaceutical Manufacturing Symposium. A project designed hand on hand in collaboration with Broward County Office of Economic & Small Business Development and FITCE. 

As we move forward in 2024 and lay out the pathway for 2025, we are proud to announce that LSIPMS will continue with the work we did during last year's theme, continuing collaborating with FITCE while this year theme will be focusing on manufacturing, we will continue collaborating and moving forward towards the development of the Life Sciences Industrial Pharmaceutical Manufacturing Park here in Florida, and helping small, mid- large size business explore the amazing investments opportunities we offer in our state, while bringing investments opportunities and solutions towards the revitalization of our domestic pharmaceutical manufacturing supply chain. 

LSIPMS is proud to invite you to stay connected and explore the countless opportunities FITCE and Florida has to offer. 

Coming out of the worse pandemic of our lifetime, and after confronting the most challenging times this generation has faced so far, these two days conference focus in raising awareness into the world's current state of readiness to prevent, detect, and respond to not only infectious diseases pandemics but also to biological, chemical outbreaks and emerging diseases.  The same is needed in the production, recovery and strengthen of our pharmaceutical supply chain. Developing strategies to build a resilient supply chain in the United States and around the world should be now our main focus.  

LSIPMS conducts, engage and support strategies to better prepare for Public Health Emergencies, works to address health disparities and health equality working through partnerships, and helping lay out the pathway straighten community engagement, connecting industry, academia and government agencies together.  We aim to build a resilient pharmaceutical supply chain and help society better prepare for the future. 

Medical devices and diagnostics play a huge role in societal needs and a lot of times are undermined because of the regulatory hurdles that come with it, or because of the complexity of their production. Technology takes a huge part in a lot of them. 

Our goal is to be able to contribute to the development and inter-active partnerships with some of our network partners and collaborators speaking from emergency medical devices such a ventilators, incubators, diagnostic testing, some of the latest trends in MRI's machines and production of it, as well as other line of medical devices such as PPE, medical gloves, face masks, robotics, biosafety mobile labs and new technologies and innovative products in development process. Join us to expand your opportunity not only to sell your products to our broad international network, but also to develop new ones, and help the health care systems to keep up with the demand. 

Clinical trials are the core of every pharmaceutical product in order to guarantee patient's safety. Discussing lessons learned from Covid and how to improve clinical trials recruitment, as well as working in decentralization of clinical trials among other diseases, is the future to be able to bring new innovative products to market, and to help ensure that new and cost-effective products are develop for patients in need.  

The future of vaccines, United States response during difficult times, the development, production, distribution of vaccines and more, are some of the topics we are aiming to bring awareness and to discuss. Partnerships, International clinical trials, joint health care ventures and more are some of the opportunities we are aiming to unfold within our network.

At LSIPMS we strive to bring together, highlight and encourage the importance of product development whether if they are innovative products aiming to get approval, or whether it is a biological product that needs support to come to life. We encourage industry, small biotech's and business all sizes to join us and participate in the plenaries designed as an arm to these important topics that includes comparisons of biosimilars - Brands vs Generics, medical device and diagnostics development, development of PPE, cancer and immunotherapy treatments and more. 

Immunotherapy and cancer treatments are personalized and categorized as precision medicine that helps the body immune system recognize and fight cancer cells. The latest trends in cancer and immunotherapy treatments, as well as navigating through the high cost and how to reduce drug prices to make them more accesible to patients in need, are some of the topics we are assembling internally.

Developing new more cost-effective cancer drugs and laying the pathway for it through regulatory approval process and clinical trials are some of our top goals to achieve. 

We keep up to date with top clinical researchers and pioneers in the industry such scientists, oncologist and physicians to walk us through the latest in treatments.

Mental health it's been a stigma in our society, and one of the most worrisome and hard topics to address during the post-covid recovery phase.  Changes in society, lockdowns during Covid, inability to have a comprehensive plan in place for children's, younger adults, middle age and elderly individuals, as well as for school systems have played a huge role in increasing the challenges to resolve it. 

According to the National Institute of Mental Health, nearly one-in-five adults live with a mental illness disorder.   At LSIPMS we are aiming to start the dialogue, bring mental health professionals together and different advocates organizations as well as federal agencies to help us designed comprehensive solutions for the future of humanity. 

In a challenging health care world, and just at the entrance of a brand-new post covid recovery era, LSIPMS is bringing together some of the most important updates in health policies, as well as a variety of some of the top health care regulatory professionals in the nation and abroad including FDA and EU professionals to get a glimpse of some of the compliance procedures implemented during the pandemic. This includes but is not limited to clinical trials recruitment and management, all the way to product development protocols updates, product approval process, drug applications, manufacturing - lab QMM Quality Management Maturity, government programs, health policy, CFR's, ICH's, FDA, federal programs, as well as representatives from different ministries of health around the world and more.  Don't miss the opportunity to come join us and discuss some of the most important trends in the healthcare industry. 

Health safety is a national security matter not only for the United States but for every nation. Securing access to the most essential pharmaceuticals and manufacturing products of our supply chain is every nation's responsibility. Ensuring production during difficult times and preparing for it, is a plan we most discuss.  Join us in an inter-agency - industry and international discussion in how to find solutions for the future of our pharmaceutical manufacturing supply chain around the world, and in how to strengthen our nation SNS Strategic National Stockpile, and in how to help other nations to do the same. 

LSIPMS focus on the development of different anti-opioids and prevention campaigns and is in the process of developing different generics and more cost-effective medicines to help mitigate this crisis and make these products more accessible not only to patients in need, but also to first responders, school systems and fire rescue, police departments as well as local, state law enforcement and to help mitigate through this crisis. 

Preparedness - Detection and Response should be the core of every nation in how to act, prevent, detect ad response in a timely manner when disaster, epidemic or a public health emergency is about to unfold or arrives. 

Strategies, solutions and lessons learned from Covid are some of the top topics we will be discussing in this session.  How to prevent and prepare for future public health emergencies is our core. Readiness for every nation should be a proactive exercise we must implement together. 

The worlds pharmaceutical supply chain was challenged during the pandemic for the lack of manufacturing and production including of the most basic products such as face mask, vaccines and biologics, antibiotics, parenteral solutions, needless, medical gloves, personal protective equipment, ventilators, ICU units and more. The stockpiling of our main consumption products should be a responsibility every nation should have and maintain in place.  

A walkthrough of our biggest challenges during the pandemic, the distribution and logistics of it, combine with geopolitical challenges and how to improve not only nationwide but worldwide, and the strategies we are developing to tackle these challenges are discussions we invite you to have and participate with us at LSIPMS to raise the awareness and combine solutions to build a resilient pharmaceutical supply chain for the next generation to come. 

CRISPR and the Future of Gene Editing. Learn the latest and most fascinating trends in science and how the top scientist is evolving to tackle our toughest diseases by designing new technologies and implementing new solutions for the future. 

At LSIPMS we stay up to date with the latest scientific developments. We encourage, support and maintain proactive in the future of medicines. 

Learn about the most and top innovative clinical trials and latest FDA approve drugs and breakthroughs in Alzheimer's disease, and how to join the force in a new promising era that signify amazing progress in our society.  

Learn from industry leaders and academia the promising evolution of regenerative medicines, it's benefits and how FDA is evolving in the development of RM, clinical trials and future approvals. 

The latest development in Islet transplantation, its future and impact in diabetes type 1, pancreas stimulation and its goals in increasing insulin production in the human body, are some of the breakthrough topics we will be covering. Honoring the pioneers in the industry and highlighting University of Miami commitment to its research and amazing scientific team. 

LSIPMS takes pride of being a FITCE ambassador and celebrates its 8th year anniversary. The goal of FITCE is to connect people, businesses, dignitaries, academia, decision making and government leaders from around the world to develop international trade, foreign direct investment and more. Taking advantage of this international opportunity enhance us to bring other nations to be part of the dialogue in how to improve our pharmaceutical supply chain in their regions and find comprehensive solutions for the future while developing business opportunities at the same time. 

We welcome you to be part of this proactive opportunity to import or export your products, make connections with different leaders and business from around 74 countries and explore the endless resources we have to offer during FITCE 2024 at The Greater Broward County Convention Center this Oct 23 - 24.